ISLAMABAD: Pakistan Tehreek-e-Insaf (PTI) founder Imran Khan was administered a fourth intravitreal eye injection at the Pakistan Institute of Medical Sciences (Pims) on Tuesday as part of his ongoing follow-up treatment, with hospital authorities saying he remained clinically stable throughout the procedure.
According to a medical update issued by Pims, Khan, currently incarcerated at Rawalpindi’s Adiala jail, was brought to the hospital for the fourth dose of intravitreal injection as part of his scheduled eye treatment.
Before the procedure, ophthalmologists examined him and found him clinically stable, while an Optical Coherence Tomography (OCT) scan showed signs of clinical improvement, the hospital said.
Following informed consent and under standard monitoring, surgeons administered the injection under microscopic guidance in the operation theatre while adopting all standard precautionary measures and protocols, according to the statement.
Pims said the procedure was performed as a day-care surgery, and Khan remained vitally stable before, during and after the treatment.
He was later discharged with instructions for further care, follow-up advice and related medical documentation, the statement added.
Tuesday’s procedure marks the latest phase in his eye care. He was earlier shifted to the hospital from Adiala jail on March 23, when he received the third dose following a comprehensive examination.
On March 18, his medical check-up was completed by a newly formed board comprising five doctors and staffers at Adiala jail following instructions from the Islamabad High Court (IHC).
The jailed PTI founder was diagnosed with central retinal vein occlusion (CRVO), a serious eye condition, according to a report submitted to the Supreme Court by his lawyer and the court’s amicus curiae, Salman Safdar.
The condition occurs when the main vein draining blood from the retina becomes blocked and is often associated with cardiovascular risk factors such as high blood pressure, high cholesterol, diabetes and heart disease.